The National Comprehensive Cancer Network has published guidelines for caregivers of cancer patients as part of its Guidelines for Patients resources. The NCCN’s “Guidelines for Patients: Caregiving for People with Cancer” are available for free on the organization’s website, according…
Research
Younger patients’ colorectal tumors had distinct cellular and genetic characteristics when compared with older patients’ tumors, according to a study published Oct. 29 in Nature Medicine. Researchers from Boston-based Dana-Farber Cancer Institute, Somerville, Mass.-based Mass General Brigham and Cambridge, Mass.-based…
A cancer mapping technology developed by researchers at Baltimore-based Johns Hopkins Medicine has been chosen to participate in Anthropic’s AI for Science program. The research project, called AstroPath, is led by Johns Hopkins astrophysicist Alexander Szalay, PhD, and Johns Hopkins’…
Pairing KRAS-targeted drugs with medicines that stop cancer cells from dividing may keep those therapies working longer in pancreatic and lung cancers, according to a preclinical study published Oct. 28 in Cancer Research. Researchers from Buffalo, N.Y.-based Roswell Park Comprehensive…
After decades of slow progress, a personalized cancer vaccine has shown a clear benefit in a phase 3 trial for the first time. Cancer leaders are now weighing how soon a vaccine built from a patient’s own tumor could become…
Average traditional Medicare costs per beneficiary with breast cancer ranged from $13,811 in Vermont to $23,232 in California in 2023, according to CMS’ Mapping Medicare Disparities tool. Total cost per beneficiary with breast cancer was highest in California, Maryland and…
The U.S. colorectal cancer incidence rate has increased for the first time in more than 20 years, according to a study published Oct. 27 in NEJM Evidence. Researchers from the University of Chicago, University of California Los Angeles, University of…
A home-based virtual supportive care program for cancer patients was associated with a 10% drop in inpatient admissions and an 8% reduction in total healthcare spending, according to research presented Oct. 16 at the 2026 ASCO Quality Care Symposium. Researchers…
States with lower breast cancer screening rates often report higher shares of breast cancers diagnosed at a regional or distant stage, according to U.S. Cancer Statistics data released in June by the CDC. The CDC classifies breast cancer stage at…
Abbott has launched an updated version of its Oncodetect blood test, which helps clinicians determine whether cancer remains in patients with solid tumors during or after treatment. The test can detect tumor DNA at levels 30 times lower than its…
